Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Rubinsteyn

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioinformatics (Oxford, England)|May 15, 2023
LENS: Landscape of Effective Neoantigens SoftwareSteven P Vensko, Kelly Olsen, Dante Bortone, et al.
Scientific Reports|February 10, 2016
Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous MalformationsEric Karl Oermann, Alex Rubinsteyn, Dale Ding, et al.
Nature Cancer|May 9, 2025
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trialMansi Saxena, Jonathan F Anker, Julia Kodysh, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Landscape and Selection of Vaccine Epitopes in SARS-CoV-2Christof C Smith, Sarah Entwistle, Caryn Willis, et al.
Science Translational Medicine|September 3, 2025
The landscape of microbial associations in human cancerAbraham Gihawi, Henry M Wood, Jeremy Clark, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT CarcinomaJeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
Genome Medicine|June 15, 2021
Landscape and selection of vaccine epitopes in SARS-CoV-2Christof C Smith, Kelly S Olsen, Kaylee M Gentry, et al.
Journal for Immunotherapy of Cancer|February 5, 2026
Shared PRAME epitopes are T-cell targets in NUT carcinomaJeffrey L Jensen, Sara K Peterson, Maria J Sambade, et al.
Immunity|February 10, 2021
Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope predictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Immunity|September 10, 2019
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope PredictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioinformatics (Oxford, England)|May 15, 2023
LENS: Landscape of Effective Neoantigens SoftwareSteven P Vensko, Kelly Olsen, Dante Bortone, et al.
Scientific Reports|February 10, 2016
Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous MalformationsEric Karl Oermann, Alex Rubinsteyn, Dale Ding, et al.
Nature Cancer|May 9, 2025
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trialMansi Saxena, Jonathan F Anker, Julia Kodysh, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Landscape and Selection of Vaccine Epitopes in SARS-CoV-2Christof C Smith, Sarah Entwistle, Caryn Willis, et al.
Science Translational Medicine|September 3, 2025
The landscape of microbial associations in human cancerAbraham Gihawi, Henry M Wood, Jeremy Clark, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT CarcinomaJeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
Genome Medicine|June 15, 2021
Landscape and selection of vaccine epitopes in SARS-CoV-2Christof C Smith, Kelly S Olsen, Kaylee M Gentry, et al.
Journal for Immunotherapy of Cancer|February 5, 2026
Shared PRAME epitopes are T-cell targets in NUT carcinomaJeffrey L Jensen, Sara K Peterson, Maria J Sambade, et al.
Immunity|February 10, 2021
Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope predictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Immunity|September 10, 2019
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope PredictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Pageof 2